Cardinal Health raises its fiscal-year adjusted earnings guidance for the second time this year, helping investors look past ...

Initiating Cardinal Health, Inc. with a Buy rating and $239 fair value, driven by specialty distribution growth and successful GMPD turnaround. Specialty segments in autoimmune, urology, and oncology ...

Cardinal Health is evolving into a specialty-focused healthcare leader, leveraging acquisitions and managed services for higher profitability and efficiency. CAH's financials show strong gross profit ...

Meet the recognizable and beloved northern cardinal. Get cardinal bird facts, including why male cardinals are red, and where ...

We've taken a closer look at Cardinal Health's quarterly results and conference call following Thursday's sell-off. Our ...

William Blair launched coverage of Cardinal Health (NYSE:CAH) with an Outperform rating today, framing the pharma distributor ...